GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis
GHAPPcast22 Jan 2025

GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis

In this GHAPP podcast episode, Jordan Mayberry, PA-C, and Patrick Horne, NP, dive deep into the complexities of chronic liver disease and its progression to cirrhosis. Drawing on over 11 years of experience in hepatology, Jordan and Patrick discuss the most common causes of liver disease, including viral hepatitis (Hepatitis B & C), alcohol-related liver disease, and metabolic-associated steatotic liver disease (MASLD) and metabolic-associated steatohepatitis (MASH). They explore the increasing prevalence of these conditions and how the rise in diagnoses is reshaping treatment strategies across the country.

Through their discussion, they explain how chronic liver diseases gradually progress, starting with liver inflammation that leads to fibrosis and eventually to cirrhosis. Understanding this progression is crucial for proper staging of liver disease and determining the right treatment approach. The episode emphasizes the importance of early diagnosis and monitoring, especially as patients transition from compensated cirrhosis (where they show no major complications) to decompensated cirrhosis, which involves severe complications like jaundice, ascites, and hepatic encephalopathy.

Special focus is given to hepatocellular carcinoma (HCC), a major risk in patients with cirrhosis. Jordan and Patrick outline the vital screening practices, including ultrasound imaging and alpha-fetoprotein testing, to detect early-stage liver cancer. With HCC being a cumulative risk, they stress the importance of regular screenings for cirrhotic patients, and the impact early detection can have on treatment outcomes, including potential liver transplant and localized therapies.


Moreover, the hosts emphasize the need for patient education—especially for those newly diagnosed with cirrhosis. Teaching patients to recognize early signs of complications ensures timely intervention and better management of their condition. Jordan and Patrick discuss how healthcare providers can play a key role in improving patient care by educating patients about the disease process, the importance of regular check-ups, and the monitoring protocols that can help manage cirrhosis and prevent further complications.


Whether you’re in hepatology practice or involved in the care of liver disease patients, this episode provides practical, actionable insights for managing chronic liver diseases and cirrhosis effectively. For more resources, visit the GHAPP website or download the GHAPP ACE app for the latest updates in liver disease management.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(161)

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this podcast episode. In this GHAPP podcast, host Christina Hanson, FNP, welcomes Janet Gripshover, DNP, FNP-BC, MBA, for a practical discussion on recognizing ...

18 Aug 48min

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module.In this FAQ video module, Natalie Oliver, PA-C, discusses how healthcare professionals can counsel patients and caregivers about overt hep...

11 Aug 4min

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module. In this FAQ video module, Samantha Ramirez, NP-C, discusses how healthcare professionals can identify and diagnose overt hepatic encephal...

4 Aug 2min

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Thank you to Johnson & Johnson for their support on this podcast episode. In this GHAPP podcast, Amy Stewart, NP, of Capital Digestive Care, introduces a practical inflammatory bowel disease discussio...

23 Jul 7min

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Thank you to AbbVie for their support of this Medication Review Video Module.In this medication review, Melissa Ferrari, PA, and Jennifer Hamilton, MSPAS, PA-C, provide a comprehensive overview of the...

30 Jun 17min

Med Review: SEQUENCE Trial: Risankizumab vs Ustekinumab in Anti-TNF-Refractory Crohn’s Disease

Med Review: SEQUENCE Trial: Risankizumab vs Ustekinumab in Anti-TNF-Refractory Crohn’s Disease

Thank you to AbbVie for their support on this Medication Review Video Module. In this medication review, Sharon Dudley-Brown, CRNP, PhD from Johns Hopkins University and Angelina Collins, MSN, ANP-BC,...

9 Jun 12min

FAQ: QUASAR Long Term Extension Interim Analysis

FAQ: QUASAR Long Term Extension Interim Analysis

Thank you to Johnson & Johnson for their support on this FAQ Video Module. In this educational video, Jamie Brogan, APRN, from Northwestern Medicine, reviews the latest QUASAR long-term extension data...

2 Jun 4min

Medication Review: Guselkumab IV vs SC Formulation

Medication Review: Guselkumab IV vs SC Formulation

Thank you to Johnson & Johnson for their support on this Medication Review Video Module. In this quick educational video, Angelina Collins, NP, from the University of California San Diego Inflammatory...

28 Mai 3min

Populært innen Helse

fastlegen
rss-gukild-johaug
lydartikler-fra-aftenposten
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-garne-damer
foreldreradet
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
g-punktet
hjernesterk
rss-lev-vel
rss-lopedrommen
treningsprat
rss-kunsten-a-leve
kjed-deg-i-sovn-verdens-kjedeligste-podcast